- Home
- PLBY vs APLT Comparison
PLBY vs APLT Comparison
Compare PLBY & APLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLBY
- APLT
- Stock Information
- Founded
- PLBY 1953
- APLT 2016
- Country
- PLBY United States
- APLT United States
- Employees
- PLBY N/A
- APLT N/A
- Industry
- PLBY Recreational Games/Products/Toys
- APLT Biotechnology: Pharmaceutical Preparations
- Sector
- PLBY Consumer Discretionary
- APLT Health Care
- Exchange
- PLBY Nasdaq
- APLT Nasdaq
- Market Cap
- PLBY 142.4M
- APLT 140.8M
- IPO Year
- PLBY N/A
- APLT 2019
- Fundamental
- Price
- PLBY $1.88
- APLT $1.10
- Analyst Decision
- PLBY Buy
- APLT Buy
- Analyst Count
- PLBY 2
- APLT 6
- Target Price
- PLBY $2.35
- APLT $6.60
- AVG Volume (30 Days)
- PLBY 742.3K
- APLT 10.8M
- Earning Date
- PLBY 11-12-2024
- APLT 11-07-2024
- Dividend Yield
- PLBY N/A
- APLT N/A
- EPS Growth
- PLBY N/A
- APLT N/A
- EPS
- PLBY N/A
- APLT N/A
- Revenue
- PLBY $124,761,000.00
- APLT N/A
- Revenue This Year
- PLBY N/A
- APLT N/A
- Revenue Next Year
- PLBY N/A
- APLT $5,117.00
- P/E Ratio
- PLBY N/A
- APLT N/A
- Revenue Growth
- PLBY 30.09
- APLT N/A
- 52 Week Low
- PLBY $0.52
- APLT $1.03
- 52 Week High
- PLBY $1.99
- APLT $10.62
- Technical
- Relative Strength Index (RSI)
- PLBY 70.93
- APLT 17.64
- Support Level
- PLBY $1.33
- APLT $1.03
- Resistance Level
- PLBY $1.99
- APLT $1.37
- Average True Range (ATR)
- PLBY 0.17
- APLT 0.33
- MACD
- PLBY 0.02
- APLT -0.15
- Stochastic Oscillator
- PLBY 85.64
- APLT 0.75
About PLBY PLBY Group Inc.
PLBY Group Inc connects consumers around the world with products, services, and experiences to help them look good, feel good, and have fun. PLBY Group serves consumers in four categories: Style and Apparel, Digital Entertainment and Lifestyle, Sexual Wellness, and Beauty and Grooming. It operates through three segments Direct-to-Consumer, Licensing, and Digital Subscriptions and Content. It generates revenue through the sales of products and content services to consumers.
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.